Adaptive Biotechnologies Corporation Common Stock (ADPT) — Analysis Summary

Adaptive Biotechnologies Corporation Common Stock (ADPT) has a market cap of $2.25B with year-over-year revenue growth of +5.1%. Net margin stands at -89.1%. The stock trades at a P/E ratio of -14.1.

Key Takeaways

• Revenue changed +5.1% year-over-year
• Net margin of -89.1%
• P/E ratio of -14.1

Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, ADPT posted revenue growth of +5.1% and trades at a P/E of -14.1.